首页> 美国卫生研究院文献>Oncotarget >The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells
【2h】

The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells

机译:H19lncRNA的敲低揭示了其在人类胚胎癌细胞多能性和肿瘤发生中的调控作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The function of imprinted H19 long non-coding RNA is still controversial. It is highly expressed in early embryogenesis and decreases after birth and re-expressed in cancer. To study the role of H19 in oncogenesis and pluripotency, we down-regulated H19 expression in vitro and in vivo in pluripotent human embryonic carcinoma (hEC) and embryonic stem (hES) cells. H19 knockdown resulted in a decrease in the expression of the pluripotency markers Oct4, Nanog, TRA-1-60 and TRA-1-81, and in the up-regulation of SSEA1; it further attenuated cell proliferation, decreased cell-matrix attachment, and up-regulated E-Cadherin expression. SCID-Beige mice transplanted with H19 down-regulated hEC cells exhibited slower kinetics of tumor formation, resulting in an increased animal survival. Tumors derived from H19 down-regulated cells showed a decrease in the expression of pluripotency markers and up-regulation of SSEA-1 and E-cadherin. Our results suggest that H19 oncogenicity in hEC cells is mediated through the regulation of the pluripotency state.
机译:印迹的H19长非编码RNA的功能仍存在争议。它在早期胚胎发生中高度表达,在出生后减少,并在癌症中重新表达。为了研究H19在肿瘤发生和多能性中的作用,我们下调了H19在体外和体内在多能人胚胎癌(hEC)和胚胎干(hES)细胞中的表达。 H19敲低导致多能性标记Oct4,Nanog,TRA-1-60和TRA-1-81的表达减少,并导致SSEA1上调。它进一步减弱了细胞增殖,降低了细胞基质附着,并上调了E-钙黏着蛋白的表达。移植了H19下调的hEC细胞的SCID-Beige小鼠表现出较慢的肿瘤形成动力学,从而提高了动物存活率。来自H19下调的细胞的肿瘤显示多能性标志物的表达下降,SSEA-1和E-钙粘蛋白的上调。我们的结果表明,hEC细胞中的H19致癌性是通过多能性状态的调节介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号